Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

Latest investments Show all
$140,000,000
Venture capital
Shoreline Biosciences
$210,000,000
Venture capital (Series B)
Umoja Biopharma
Team Size
1–10
Employees
Geographical Focus
Past year's investments

Cormorant Asset Management participated in fewer than 3 rounds over the past year

Latest rounds
  • Shoreline Biosciences: Venture capital ($140M)
  • Umoja Biopharma: Venture capital (Series B) ($210M)
  • Visen Pharmaceuticals: Venture capital (Series B) ($150M)